TMEM199 Protein — Transmembrane Protein 199

TMEM199 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TMEM199 Protein — Transmembrane Protein 199</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TMEM199</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transmembrane Protein 199</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>54778</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2H5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~45 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TMEM family</td>
</tr>
<tr>
<td class="label">Topology</td>
<td>Multi-pass transmembrane (8-10 TM domains)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Lysosomal membrane, endoplasmic reticulum</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Role</td>
</tr>
<tr>
<td class="label">mTORC1 Signaling</td>
<td>Lysosomal nutrient sensing</td>
</tr>
<tr>
<td class="label">V-ATPase Complex</td>
<td>Lysosomal acidification</td>
</tr>
<tr>
<td class="label">Autophagy-Lysosome Pathway</td>
<td>Autophagosome maturation</td>
</tr>
<tr>
<td class="label">ERAD Pathway</td>
<td>Protein quality control</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>AAV-TMEM199 delivery</td>
</tr>
<tr>
<td class="lab

...

TMEM199 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">TMEM199 Protein — Transmembrane Protein 199</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TMEM199</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Transmembrane Protein 199</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>54778</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9Y2H5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~45 kDa</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>TMEM family</td>
</tr>
<tr>
<td class="label">Topology</td>
<td>Multi-pass transmembrane (8-10 TM domains)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Lysosomal membrane, endoplasmic reticulum</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Role</td>
</tr>
<tr>
<td class="label">mTORC1 Signaling</td>
<td>Lysosomal nutrient sensing</td>
</tr>
<tr>
<td class="label">V-ATPase Complex</td>
<td>Lysosomal acidification</td>
</tr>
<tr>
<td class="label">Autophagy-Lysosome Pathway</td>
<td>Autophagosome maturation</td>
</tr>
<tr>
<td class="label">ERAD Pathway</td>
<td>Protein quality control</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>AAV-TMEM199 delivery</td>
</tr>
<tr>
<td class="label">Lysosomal Enhancement</td>
<td>Small molecule activators</td>
</tr>
<tr>
<td class="label">Autophagy Modulation</td>
<td>[mTOR](/entities/mtor)-independent pathways</td>
</tr>
<tr>
<td class="label">Protein Replacement</td>
<td>Enzyme replacement therapy</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Introduction

Tmem199 Protein — Transmembrane Protein 199 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

TMEM199 (Transmembrane Protein 199) is a multipass transmembrane protein localized primarily to the lysosomal membrane[@peng2016]. It plays a critical role in maintaining lysosomal function, including acidification, nutrient sensing, and autophagy. TMEM199 is encoded by the TMEM199 gene on chromosome 17q12.

Lysosomal dysfunction is a central feature of many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and neuronal ceroid lipofuscinoses (Batten disease)[@nixon2020]. TMEM199 mutations have been linked to childhood-onset neurodegeneration, highlighting its importance in neuronal survival.

Gene and Protein Information

Molecular Function

Structure

• Transmembrane Domains: 8-10 predicted alpha-helical transmembrane segments
• Lysosomal Lumenal Loop: Large lumenal loop potentially involved in substrate binding
• Cytoplasmic N- and C-termini: Accessible for protein interactions and signaling

Biochemical Functions

Lysosomal Acidification: Contributes to V-ATPase complex assembly or regulation

Nutrient Sensing: Interfaces with mTORC1 signaling pathway

[Autophagy](/entities/autophagy) Regulation: Essential for autophagosome-lysosome fusion

Lipid Metabolism: Involved in cholesterol trafficking

Ion Homeostasis: May function as ion channel or transporter

Interacting Pathways

Expression and Localization

Tissue Distribution

• Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum
• Neuronal Expression: Predominantly neuronal with glial expression
• Subcellular: Lysosomal and ER localization
• Cellular Compartment: Enriched in late endosomes and lysosomes

Lysosomal Function

• pH Maintenance: Essential for lysosomal acidification (optimal pH 4.5-5.0)
• Enzyme Activity: Provides environment for hydrolytic enzyme function
• Cargo Degradation: Facilitates breakdown of proteins, lipids, and organelles
• Recycling: Enables nutrient recovery through macropinocytosis

Disease Associations

Alzheimer's Disease

• Reduced TMEM199 expression in AD brain[@wolfe2023]
• Impaired lysosomal function contributes to amyloid accumulation
• Autophagy-lysosomal pathway disruption in AD pathogenesis
• May affect [tau](/proteins/tau) degradation and spread

Parkinson's Disease

• Lysosomal dysfunction in PD dopaminergic [neurons](/entities/neurons)
• [Alpha-synuclein](/proteins/alpha-synuclein) clearance requires functional lysosomes
• TMEM199 may modify PD risk through autophagy pathways
• Mitochondrial-lysosomal cross-talk affected

Amyotrophic Lateral SALS

• Motor neurons particularly vulnerable to lysosomal dysfunction
• Protein aggregate clearance impaired
• Altered autophagy in ALS pathogenesis

Other Lysosomal Storage Disorders

• Congenital Disorders of Glycosylation: TMEM199 mutations cause CDG type II
• Childhood Neurodegeneration: TMEM199 deficiency causes progressive encephalopathy

Pathogenic Mechanisms

Lysosomal Acidification Defect: Impaired pH disrupts hydrolytic activity

Autophagy Block: Failure of autophagosome-lysosome fusion

Protein Aggregate Accumulation: Reduced clearance of misfolded proteins

Lipid Trafficking Defect: Cholesterol and lipid accumulation

Neuronal Vulnerability: Energy deficit and oxidative stress

Therapeutic Implications

Treatment Strategies

Drug Development Targets

• V-ATPase Modulators: Enhance lysosomal acidification
• Autophagy Inducers: Bypass TMEM199 deficiency
• Gene Therapy Vectors: CNS-targeted AAV delivery
• Combination Approaches: Multiple pathway targeting

Research Methods

• CRISPR-Cas9: Gene editing for functional studies
• Proteomics: Interaction partner identification
• Lysosomal Fractionation: Subcellular localization studies
• iPSC Models: Patient-derived neuronal models

Animal Models

• Knockout Mice: embryonic lethal in homozygotes
• Conditional Knockouts: Neuron-specific deletion phenotypes
• Zebrafish: Developmental studies and behavioral analysis

Background

The study of Tmem199 Protein — Transmembrane Protein 199 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-References

• [Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway)
• [Protein Quality Control](/mechanisms/protein-quality-control-network)mechanisms/protein-quality-control-network)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neurodegeneration](/diseases/neurodegeneration)

See Also

• [Lysosomal Storage Disorders](/diseases/lysosomal-storage-disorders)
• [Autophagy](/mechanisms/autophagy-lysosomal-pathway)
• [mTOR Signaling](/mechanisms/mtor-signaling-neurodegeneration)
• [Protein Aggregation](/mechanisms/protein-aggregation)
• [V-ATPase](/proteins/vatpase-protein)

External Links

• [NCBI Gene: TMEM199](https://www.ncbi.nlm.nih.gov/gene/54778)
• [UniProt: Q9Y2H5](https://www.uniprot.org/uniprot/Q9Y2H5)
• [AlphaFold: TMEM199](https://alphafold.ebi.ac.uk/entry/Q9Y2H5)
• [PubMed: TMEM199](https://pubmed.ncbi.nlm.nih.gov/?term=TMEM199)

References

[Peng Y, et al, TMEM199 deficiency causes a novel congenital disorder of glycosylation (2016)](https://pubmed.ncbi.nlm.nih.gov/27506621/)

[Nixon RA, The role of autophagy in neurodegenerative disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32617415/)

[Wolfe DM, et al, Autophagy failure in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36944978/)